These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 32399442)
1. Hepatic Necrosis after Trans-Arterial Embolization of Metastatic Neuroendocrine Tumour. Micallef S; Cortis K; Magri C Eur J Case Rep Intern Med; 2020; 7(5):001530. PubMed ID: 32399442 [TBL] [Abstract][Full Text] [Related]
2. Transarterial (chemo)embolisation versus no intervention or placebo for liver metastases. Swierz MJ; Storman D; Riemsma RP; Wolff R; Mitus JW; Pedziwiatr M; Kleijnen J; Bala MM Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009498. PubMed ID: 32163181 [TBL] [Abstract][Full Text] [Related]
3. Hepatic arterial embolization in patients with neuroendocrine tumors. Del Prete M; Fiore F; Modica R; Marotta V; Marciello F; Ramundo V; Di Sarno A; Carratù A; di Roseto Cde L; Tafuto S; Tatangelo F; Baldelli R; Colao A; Faggiano A; J Exp Clin Cancer Res; 2014 May; 33(1):43. PubMed ID: 24887262 [TBL] [Abstract][Full Text] [Related]
4. Hepatic Arterial Infusion Chemotherapy Using Oxaliplatin Plus 5-Fluorouracil Versus Transarterial Chemoembolization/Embolization for the Treatment of Advanced Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis. Hu J; Bao Q; Cao G; Zhu X; Yang R; Ji X; Xu L; Zheng K; Li W; Xing B; Wang X Cardiovasc Intervent Radiol; 2020 Jul; 43(7):996-1005. PubMed ID: 31974744 [TBL] [Abstract][Full Text] [Related]
5. Role of hepatic intra-arterial therapies in metastatic neuroendocrine tumours (NET): guidelines from the NET-Liver-Metastases Consensus Conference. Kennedy A; Bester L; Salem R; Sharma RA; Parks RW; Ruszniewski P; HPB (Oxford); 2015 Jan; 17(1):29-37. PubMed ID: 25186181 [TBL] [Abstract][Full Text] [Related]
6. Trans-arterial therapy for Fibrolamellar carcinoma: A case report and literature review. Bernon MM; Gandhi K; Allam H; Singh S; Kloppers J; Jonas E Int J Surg Case Rep; 2022 May; 94():106980. PubMed ID: 35421728 [TBL] [Abstract][Full Text] [Related]
7. Transarterial embolization (TAE) is equally effective and slightly safer than transarterial chemoembolization (TACE) to manage liver metastases in neuroendocrine tumors. Fiore F; Del Prete M; Franco R; Marotta V; Ramundo V; Marciello F; Di Sarno A; Carratù AC; de Luca di Roseto C; Colao A; Faggiano A Endocrine; 2014 Sep; 47(1):177-82. PubMed ID: 24385266 [TBL] [Abstract][Full Text] [Related]
8. Transcatheter Arterial Embolization for Hepatic Arterial Injury Related to Percutaneous Transhepatic Portal Intervention. Shimohira M; Hashizume T; Sasaki S; Ohta K; Suzuki K; Nakagawa M; Ozawa Y; Sakurai K; Nishikawa H; Hara M; Shibamoto Y Cardiovasc Intervent Radiol; 2017 Feb; 40(2):291-295. PubMed ID: 27663693 [TBL] [Abstract][Full Text] [Related]
9. Hepatic artery embolization in advanced neuroendocrine tumors: Efficacy and long-term outcomes. Pericleous M; Caplin ME; Tsochatzis E; Yu D; Morgan-Rowe L; Toumpanakis C Asia Pac J Clin Oncol; 2016 Mar; 12(1):61-9. PubMed ID: 26663886 [TBL] [Abstract][Full Text] [Related]
16. Hepatic parenchymal changes following transcatheter embolization and chemoembolization in a rabbit tumor model. Wang Y; Xiong B; Liang B; Zhao H; Li H; Qian J; Liang HM; Feng GS; Zheng CS PLoS One; 2013; 8(8):e70757. PubMed ID: 23967098 [TBL] [Abstract][Full Text] [Related]
17. Case Report: Complete Necrosis of a Large Adrenocortical Cancer and Liver Metastases Achieved by Selective Arterial Embolization: A Case Study and Review of Literature. Huszty G; Doros A; Farkas K; Kóbori L; Reismann P; Tőke J; Tóth M; Igaz P Front Endocrinol (Lausanne); 2021; 12():677187. PubMed ID: 33995288 [TBL] [Abstract][Full Text] [Related]
18. Multiple liver metastases of pulmonary carcinoid successfully treated by two-stage hepatectomy combined with embolization of portal vein branches: Report of a case. Kamada T; Onda S; Takano Y; Sakamoto T; Kikuchi R; Yanaga K Int J Surg Case Rep; 2020; 71():319-322. PubMed ID: 32492643 [TBL] [Abstract][Full Text] [Related]
19. [A patient with hepatocellular carcinoma and portal vein thrombosis in 1st branch who was treated by transcatheter arterial embolization]. Yamamoto T; Nagano H; Sakon M; Miyamoto A; Kondo M; Arai I; Morimoto O; Dono K; Umeshita K; Nakamori S; Murakami T; Nakamura H; Monden M Gan To Kagaku Ryoho; 2001 Oct; 28(11):1718-23. PubMed ID: 11708017 [TBL] [Abstract][Full Text] [Related]
20. Outcome and prognostic factors of spontaneous ruptured hepatocellular carcinoma treated with transarterial embolization. Shin BS; Park MH; Jeon GS Acta Radiol; 2011 Apr; 52(3):331-5. PubMed ID: 21498371 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]